RINVOQ is the first and only systemic medication approved in the European Union to treat adult and adolescent patients with non-segmental vitiligo (NSV) who are candidates for systemic therapy Phase 3 ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...

SINGING has provided a soundtrack to human history. Songs tell people about their past and their values. Ancient epics, which ...

Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter ...

The ACT for ALS Reauthorization Act passed Congress on September 28, and Gail Kim credited Tanea "Rebel" Brooks and the ...

The New Era of Tumor-Agnostic Cancer Therapy / ALK, Allen Chen, BCR ABL, Bence Jones proteins, biomarkers, BRAF, CA 19-9, ...

From Andy Pandy onwards, children’s TV has been an apolitical sanctuary where parents can relax, knowing their little ones ...

It was 11 PM, and I was scrolling through the app while lying in bed, only to realize an hour had passed. Even as the number ...

Queensland scientists at Mater Research have developed a targeted cancer therapy combining low-dose chemotherapy with a ...

Concoria Parish Academy freshman Destineé Davis scored a 20 on the ACT after eighth grade, exceeding the national average as ...

Speaking in extended clips from the latest episode of “60 Minutes,” the 36-year-old said that EMDR, a trauma-focused psychotherapy, helped him face what he was dealing with “head ...

Virtuix Holdings Inc. has announced a partnership with The LP Foundation, Rutgers University WINLAB, and Sirica Therapeutics ...